08:39 AM EDT, 07/09/2025 (MT Newswires) -- Bausch Health ( BHC ) Canada said Wednesday its Cabtreo treatment for acne vulgaris has been made available to beneficiaries of the public drug plans of Ontario and Nova Scotia.
The treatment is also available through the Candian government's Non-Insured Health Benefits drug plan for Indigenous populations and through the Correctional Service of Canada, the company said.
Bausch Health Canada General Manager Amy Cairns said the company plans to complete listing arrangements with other public drug plans in Canada "in the near future."